We found PRMT5 to be higher expressed in CLL samples than in memory B cells, but lower than in germinal center B cells, while DAD1 showed overall higher expression but also higher variability in CLL samples. Here, PRMT5 is linked to B-cell chronic lymphocytic leukemia.